New England Journal of Medicine Retracts Amgen Drug Trial Paper Amid Data Integrity Concerns
The New England Journal of Medicine (NEJM) has retracted a significant clinical trial paper that provided evidence for Amgen’s drug Tavneos. The retraction follows concerns raised about the integrity of the patient outcome data and allegations that some researchers involved in the study were unblinded. The paper, which played a role in the drug’s supportive […]